Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Stan Caplan and the BoD

"The Core Flash portilio and the subsequent licenses received by TPL, should in theory be minute relative to the value of the MMP."

“Leckrone potentially piggy backing on negotiations to pocket a few million just doesn't make sense to me. Are we to believe he issued 75 licenses at potentially discounted prices just to bag the Core Flash license?”

---------

Seems to me if the value of the MMP IS many time greater then the Core Flash then there is significant advantage to skewing the distribution. Perhaps your confusion in the math can be explained in this way…

If MMP is only 4 times more valuable then Core. Then a “deal” for 10 million should split 2 MM for Core and 8MM for MMP. BUT what if the “deal maker” makes the deal and assigns the value received as being 4MM for Core and 6MM for MMP?

Same amount of money from the payer; MMP is down 2MM (or -25%) BUT Core is up 2MM (or 100%; a double). So the issue is not one of little gain for TPL, as with these numbers at least, it would double the cash into TPL.

The higher you value the MMP against Core the greater the advantage to TPL for skewing the numbers. Do the math on higher valuations. The numbers (and advantage for skewing the distributions) get interesting very quickly.

Share
New Message
Please login to post a reply